Rocío Ferreiro‐Iglesias

Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study

Manuel Barreiro‐de Acosta, Nicolau Vallejo, Daniel de la Iglesia et al. · Journal of Crohn s and Colitis · 2015 · 212 citations · Full text

Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre Study

Carlos Chavarría, María José Casanova, María Chaparro et al. · Journal of Crohn s and Colitis · 2019 · 96 citations

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study

María Chaparro, Ana Garre, Andrea Núñez Ortiz et al. · Journal of Clinical Medicine · 2021 · 92 citations · Full text

Real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry

Marisa Iborra, Belén Beltrán, A Fernández-Clotet et al. · Alimentary Pharmacology & Therapeutics · 2019 · 70 citations

Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy

Rocío Ferreiro‐Iglesias, Manuel Barreiro‐de Acosta, Manuel Otero Santiago et al. · Journal of Clinical Gastroenterology · 2015 · 67 citations